SCHEMBL6753903

SCHEMBL6753903

[CH2]/C=C/c1cncc(-c2ccccn2)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 1/20 0.49
RAF1 P04049 1/20 0.48
TLR4 O00206 1/20 0.43
TLR2 O60603 1/20 0.43
GRM5 P41594 1/20 0.40
KDM4E B2RXH2 5/20 0.39
LMNA P02545 3/20 0.39
CCR1 P32246 3/20 0.39
CCR5 P51681 3/20 0.39
CCR8 P51685 3/20 0.39
CYP1A2 P05177 1/20 0.39
POLB P06746 1/20 0.39
METAP1 P53582 1/20 0.39
BLM P54132 1/20 0.39
HIF1A Q16665 1/20 0.39
DOHH Q9BU89 1/20 0.39
P4HTM Q9NXG6 1/20 0.39
NPC1 O15118 4/20 0.38
RAB9A P51151 4/20 0.38
MEN1 O00255 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6651703 0.82 CYP2A6 (0.50) CYP2A6RAF1TLR4TLR2GRM5
SCHEMBL6651709 0.82 CYP2A6 (0.50) CYP2A6RAF1TLR4TLR2GRM5
SCHEMBL14634355 0.81 CYP2A6 (0.56) CYP2A6RAF1TLR4TLR2GRM5
SCHEMBL4821815 0.81 TLR4 (0.62) CYP2A6TLR4TLR2KDM4ELMNA
SCHEMBL6654480 0.80 CYP2A6 (0.41) CYP2A6RAF1NPC1RAB9AMEN1
SCHEMBL6654481 0.80 CYP2A6 (0.41) CYP2A6RAF1NPC1RAB9AMEN1
SCHEMBL2462770 0.79 CYP2A6 (0.67) CYP2A6GRM5KDM4ELMNACCR1
SCHEMBL4818701 0.78 KDM4E (0.46) CYP2A6TLR4TLR2KDM4ELMNA
SCHEMBL7027876 0.78 KDM4E (0.46) CYP2A6TLR4TLR2KDM4ELMNA
SCHEMBL4822196 0.78 PTGS2 (0.42) CYP1A2KDM1AHDAC1HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1589277-A 6-O-carbamate-11,12-lacto-ketolide antimicrobials ORTHO MCNEIL PHARM INC (US) 2005-03-02 CN disclosed
US-6713455-B2 A BICYCLIC HETEROAROMATIC COMPOUND CONTAINING TWO KETO, TWO ESTER, A CARBAMATE GROUPS AND A METHYL, HYDROXY AND AMINE SUBSTITUTED OXYPYRAN RING; USEFUL ANTIBACTERIAL AGENT FOR TREATING PNEUMONIA, SKIN, SOFT TISSUE AND BONE INFECTIONS ORTHO-MCNEIL PHARMACEUTICAL, INC. 2004-03-30 US disclosed
US-20030125267-A1 6-O-carbamate-11,12-lacto-ketolide antimicrobials ORTHO-MCNEIL PHARMACEUTICAL, INC. 2003-07-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030125267-A1 6-O-carbamate-11,12-lacto-ketolide antimicrobials ARG1, LPO, Q6ZSR9 CYP2A6 601/4885RAF1 1404/4885TLR4 3039/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.